Chelation therapy is a proven, safe IV treatment to improve circulation and cell health and avoid surgery. For 60 years chelation therapy has served as a highly effective and safe intravenous treatment for the elimination of toxic heavy metals and improvement of circulation and health. Atherosclerosis — the narrowing and stiffening of arteries due to the accumulation of pathologic calcium and plaque — is a primary cause of diminished circulation and oxygen to our cells. EDTA chelation treatment is a cost-effective method for avoiding surgery, enhancing the health of the arteries, removing pathologic calcium, improving elasticity, and thus improving circulation.
Chelation involves the intravenous administration of a synthetic amino acid called EDTA (ethylene diamine tetra-acetic acid). EDTA (in a complex with magnesium, vitamin C, and other nutrients) enters the bloodstream by the intravenous route and binds to heavy metals such as lead, iron and cadmium that can cause free-radical damage, and calcium deposits in the arteries, and carries them harmlessly out of the body through the urine.
This treatment reduces toxic metal-induced free radicals, which cause the development of arteriosclerosis and many other degenerative diseases of aging.
Chelation has a 60-year history of safety and effectiveness recorded by physicians certified to administer the therapy and following the proper protocols, and is currently available at The Karlfeldt Center in Meridian, Idaho. Over those six decades, more than one million patients have undergone chelation therapy for a wide range of circulatory problems, such as: